Uncertainties surrounding the U.S. pharmaceutical sector and the turbulent development in global stock markets have led to ...

Over the last year, 89bio’s stock has been somewhat volatile. Shares climbed past $10 earlier this year, but dropped under $6 ...

This article summarizes the most significant insider buys and sells for US stocks reported on Friday, April 11, 2025.

NEW YORK CITY, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Analyst Price Forecast Suggests 35.52% Upside As of April 2, 2025, the average one-year price target for Tempest Therapeutics is $9.69/share. The forecasts range from a low of $5.05 to a high of ...

Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.

Get the next trade alert free. Vera Therapeutics, Inc. VERA said on Wednesday that it had completed full enrollment (431 participants) in the pivotal ORIGIN Phase 3 trial of atacicept in patients ...

Introduced in FY23, Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers ...

Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed ...

If you own Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO), please contact Fletcher Moore by email at [email protected] or (212) 709-8245. You may be able to seek monetary damages ...

If you own Akero Therapeutics, Inc. ("Akero") (NASDAQ:AKRO ), please contact Fletcher Moore by email at ... or (212) 709-8245. You may be able to seek monetary damages, corporate governance ...

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by ...